Braskem (BAK) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

BAK Stock Forecast

Braskem stock forecast is as follows: an average price target of $9.25 (represents a 130.67% upside from BAK’s last price of $4.01) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.

BAK Price Target

The average price target for Braskem (BAK) is $9.25 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $10.00 to $8.50. This represents a potential 130.67% upside from BAK's last price of $4.01.

BAK Analyst Ratings

Buy

According to 4 Wall Street analysts, Braskem's rating consensus is 'Buy'. The analyst rating breakdown for BAK stock is 0 'Strong Buy' (0.00%), 3 'Buy' (75.00%), 1 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Braskem Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Sep 18, 2024	Luiz Carvalho	UBS	$10.00	$6.91	44.72%	149.38%
Sep 03, 2024	Vicente Neto	Bradesco	$8.50	$6.33	34.18%	111.97%

The latest Braskem stock forecast, released on Sep 18, 2024 by Luiz Carvalho from UBS, set a price target of $10.00, which represents a 44.72% increase from the stock price at the time of the forecast ($6.91), and a 149.38% increase from BAK last price ($4.01).

Braskem Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	2
Avg Price Target	-	-	$9.25
Last Closing Price	$4.01	$4.01	$4.01
Upside/Downside	-100.00%	-100.00%	130.67%

In the current month, the average price target of Braskem stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Braskem's last price of $4.01. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	New Rating	Rating Change
Dec 13, 2024	Santander	Neutral	Downgrade
Sep 18, 2024	UBS	Buy	Upgrade
Sep 03, 2024	Bradesco	Outperform	Upgrade
Aug 19, 2024	Citigroup	Buy	Upgrade

Braskem's last stock rating was published by Santander on Dec 13, 2024. The company Downgrade its BAK rating from "null" to "Neutral".

Braskem Financial Forecast

Braskem Revenue Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17
Revenue	-	-	-	-	-	-	-	-	-	-	-	$19.45B	$18.99B	$25.39B	$25.41B	$26.73B	$28.21B	$28.30B	$26.42B	$22.69B	$18.74B	$15.99B	$11.19B	$12.62B	$12.64B	$13.37B	$13.34B	$12.98B	$13.03B	$12.60B
Avg Forecast	$25.10B	$24.28B	$23.49B	$22.72B	$16.95B	$20.36B	$19.22B	$17.74B	$16.54B	$15.07B	$17.60B	$19.50B	$20.17B	$24.62B	$26.65B	$24.32B	$29.49B	$27.26B	$24.85B	$23.23B	$15.96B	$14.74B	$12.82B	$11.22B	$11.04B	$13.45B	$12.89B	$13.52B	$31.01B	$38.79B
High Forecast	$27.34B	$26.45B	$25.58B	$24.75B	$17.95B	$22.17B	$19.22B	$17.74B	$17.53B	$16.42B	$19.17B	$21.23B	$21.97B	$24.62B	$26.65B	$24.32B	$29.49B	$27.26B	$24.85B	$23.23B	$15.96B	$14.74B	$12.82B	$11.22B	$11.04B	$13.45B	$12.89B	$13.52B	$37.21B	$46.55B
Low Forecast	$23.44B	$22.68B	$21.94B	$21.22B	$15.89B	$19.01B	$19.22B	$17.74B	$15.50B	$14.08B	$16.43B	$18.21B	$18.84B	$24.62B	$26.65B	$24.32B	$29.49B	$27.26B	$24.85B	$23.23B	$15.96B	$14.74B	$12.82B	$11.22B	$11.04B	$13.45B	$12.89B	$13.52B	$24.81B	$31.03B
# Analysts	1	1	1	1	3	2	1	1	2	1	1	1	1	1	1	1	1	1	1	1	12	16	9	9	8	9	13	17	19	20
Surprise %	-	-	-	-	-	-	-	-	-	-	-	1.00%	0.94%	1.03%	0.95%	1.10%	0.96%	1.04%	1.06%	0.98%	1.17%	1.08%	0.87%	1.13%	1.15%	0.99%	1.03%	0.96%	0.42%	0.32%

Braskem's average Quarter revenue forecast for Jun 23 based on 1 analysts is $17.60B, with a low forecast of $16.43B, and a high forecast of $19.17B. BAK's average Quarter revenue forecast represents a -9.49% decrease compared to the company's last Quarter revenue of $19.45B (Mar 23).

Braskem EBITDA Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17
# Analysts	1	1	1	1	3	2	1	1	2	1	1	1	1	1	1	1	1	1	1	1	12	16	9	9	8	9	13	17	19	20
EBITDA	-	-	-	-	-	-	-	-	-	-	-	$1.68B	$-652.00M	$2.45B	$3.23B	$5.16B	$4.31B	$5.61B	$12.17B	$5.98B	$4.27B	$-249.00M	$-1.16B	$-3.70B	$-3.60B	$379.80M	$1.72B	$2.62B	$2.58B	$3.73B
Avg Forecast	$2.09B	$2.03B	$1.96B	$1.90B	$1.41B	$1.70B	$1.60B	$1.48B	$1.38B	$1.26B	$1.47B	$1.63B	$-13.41B	$2.70B	$2.92B	$2.66B	$3.23B	$2.99B	$2.72B	$2.54B	$1.75B	$1.61B	$-4.86B	$1.23B	$1.21B	$9.35B	$1.41B	$1.48B	$6.13B	$11.50B
High Forecast	$2.28B	$2.21B	$2.13B	$2.06B	$1.50B	$1.85B	$1.60B	$1.48B	$1.46B	$1.37B	$1.60B	$1.77B	$-10.73B	$2.70B	$2.92B	$2.66B	$3.23B	$2.99B	$2.72B	$2.54B	$1.75B	$1.61B	$-3.88B	$1.23B	$1.21B	$11.22B	$1.41B	$1.48B	$7.36B	$13.79B
Low Forecast	$1.96B	$1.89B	$1.83B	$1.77B	$1.33B	$1.59B	$1.60B	$1.48B	$1.29B	$1.17B	$1.37B	$1.52B	$-16.09B	$2.70B	$2.92B	$2.66B	$3.23B	$2.99B	$2.72B	$2.54B	$1.75B	$1.61B	$-5.83B	$1.23B	$1.21B	$7.48B	$1.41B	$1.48B	$4.91B	$9.20B
Surprise %	-	-	-	-	-	-	-	-	-	-	-	1.04%	0.05%	0.91%	1.11%	1.94%	1.34%	1.88%	4.47%	2.35%	2.45%	-0.15%	0.24%	-3.01%	-2.98%	0.04%	1.22%	1.77%	0.42%	0.32%

1 analysts predict BAK's average Quarter EBITDA for Jun 23 to be $1.47B, with a high of $1.60B and a low of $1.37B. This is -12.82% lower than Braskem's previous annual EBITDA (Mar 23) of $1.68B.

Braskem Net Income Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17
# Analysts	1	1	1	1	3	2	1	1	2	1	1	1	1	1	1	1	1	1	1	1	12	16	9	9	8	9	13	17	19	20
Net Income	-	-	-	-	-	-	-	-	-	-	-	$184.00M	$-1.88B	$-1.42B	$-1.46B	$3.88B	$468.00M	$3.54B	$7.42B	$2.49B	$846.00M	$-1.34B	$-2.50B	$-4.06B	$-2.63B	$-986.36M	$102.00M	$1.03B	$1.05B	$1.81B
Avg Forecast	$-539.79M	$-566.78M	$-539.79M	$-742.21M	$-1.62B	$-719.81M	$-4.65B	$12.98B	$-1.35B	$-1.92B	$-1.18B	$14.01B	$-80.42B	$851.47M	$3.04B	$13.83B	$8.00B	$9.40B	$11.90B	$13.70B	$4.34B	$-813.64M	$-10.39B	$-6.43B	$-700.34M	$-21.85B	$-251.39M	$-287.47M	$2.51B	$5.56B
High Forecast	$-493.32M	$-518.00M	$-493.32M	$-678.32M	$-1.48B	$-657.86M	$-4.25B	$15.57B	$-1.23B	$-1.75B	$-1.08B	$16.81B	$-64.33B	$851.47M	$3.04B	$16.59B	$8.00B	$9.40B	$11.90B	$16.44B	$4.34B	$-813.64M	$-8.31B	$-6.43B	$-700.34M	$-17.48B	$-251.39M	$-287.47M	$3.01B	$6.68B
Low Forecast	$-602.30M	$-632.42M	$-602.30M	$-828.16M	$-1.81B	$-803.18M	$-5.19B	$10.38B	$-1.50B	$-2.14B	$-1.31B	$11.21B	$-96.50B	$851.47M	$3.04B	$11.06B	$8.00B	$9.40B	$11.90B	$10.96B	$4.34B	$-813.64M	$-12.47B	$-6.43B	$-700.34M	$-26.22B	$-251.39M	$-287.47M	$2.01B	$4.45B
Surprise %	-	-	-	-	-	-	-	-	-	-	-	0.01%	0.02%	-1.67%	-0.48%	0.28%	0.06%	0.38%	0.62%	0.18%	0.20%	1.64%	0.24%	0.63%	3.75%	0.05%	-0.41%	-3.57%	0.42%	0.32%

Braskem's average Quarter net income forecast for Jun 23 is $-1.18B, with a range of $-1.31B to $-1.08B. BAK's average Quarter net income forecast represents a -739.44% decrease compared to the company's last Quarter net income of $184.00M (Mar 23).

Braskem SG&A Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17
# Analysts	1	1	1	1	3	2	1	1	2	1	1	1	1	1	1	1	1	1	1	1	12	16	9	9	8	9	13	17	19	20
SG&A	-	-	-	-	-	-	-	-	-	-	-	$1.09B	$1.33B	$1.20B	$1.18B	$1.16B	$1.35B	$1.19B	$1.05B	$991.00M	$1.07B	$928.00M	$872.00M	$904.36M	$1.15B	$1.01B	$936.00M	$931.76M	$676.35M	$656.87M
Avg Forecast	$1.49B	$1.44B	$1.40B	$1.35B	$1.01B	$1.21B	$1.14B	$3.88B	$982.31M	$895.41M	$1.05B	$4.19B	$1.20B	$1.47B	$1.59B	$4.14B	$1.76B	$1.63B	$1.48B	$5.44B	$951.58M	$879.14M	$3.66B	$668.88M	$658.20M	$802.36M	$768.71M	$806.01M	$1.61B	$2.02B
High Forecast	$1.62B	$1.57B	$1.52B	$1.47B	$1.07B	$1.32B	$1.14B	$4.66B	$1.04B	$975.17M	$1.14B	$5.03B	$1.30B	$1.47B	$1.59B	$4.96B	$1.76B	$1.63B	$1.48B	$6.53B	$951.58M	$879.14M	$4.39B	$668.88M	$658.20M	$802.36M	$768.71M	$806.01M	$1.93B	$2.43B
Low Forecast	$1.39B	$1.35B	$1.30B	$1.26B	$944.17M	$1.13B	$1.14B	$3.11B	$920.56M	$836.12M	$976.27M	$3.35B	$1.12B	$1.47B	$1.59B	$3.31B	$1.76B	$1.63B	$1.48B	$4.35B	$951.58M	$879.14M	$2.93B	$668.88M	$658.20M	$802.36M	$768.71M	$806.01M	$1.29B	$1.62B
Surprise %	-	-	-	-	-	-	-	-	-	-	-	0.26%	1.11%	0.82%	0.74%	0.28%	0.77%	0.73%	0.71%	0.18%	1.12%	1.06%	0.24%	1.35%	1.74%	1.26%	1.22%	1.16%	0.42%	0.32%

Braskem's average Quarter SG&A projection for Jun 23 is $1.05B, based on 1 Wall Street analysts, with a range of $976.27M to $1.14B. The forecast indicates a -4.35% fall compared to BAK last annual SG&A of $1.09B (Mar 23).

Braskem EPS Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17
# Analysts	1	1	1	1	3	2	1	1	2	1	1	1	1	1	1	1	1	1	1	1	12	16	9	9	8	9	13	17	19	20
EPS	-	-	-	-	-	-	-	-	-	-	-	$0.46	$-4.73	$-3.57	$-3.67	$9.76	$1.18	$8.89	$18.65	$6.26	$2.13	$-3.36	$-6.27	$-10.20	$-6.61	$-2.48	$0.26	$2.58	$2.65	$4.54
Avg Forecast	$-0.68	$-0.71	$-0.68	$-0.93	$-2.03	$-0.90	$-5.83	$-2.43	$-1.69	$-2.41	$-1.48	$-0.67	$-2.49	$1.07	$3.81	$7.66	$10.03	$11.79	$14.92	$5.97	$5.44	$-1.02	$-4.24	$-8.07	$-0.88	$-0.54	$-0.32	$-0.36	$1.52	$2.10
High Forecast	$-0.62	$-0.65	$-0.62	$-0.85	$-1.86	$-0.83	$-5.33	$-2.22	$-1.55	$-2.20	$-1.35	$-0.61	$-2.27	$1.07	$3.81	$7.66	$10.03	$11.79	$14.92	$5.97	$5.44	$-1.02	$-4.24	$-8.07	$-0.88	$-0.54	$-0.32	$-0.36	$1.82	$2.51
Low Forecast	$-0.76	$-0.79	$-0.76	$-1.04	$-2.27	$-1.01	$-6.51	$-2.71	$-1.89	$-2.69	$-1.65	$-0.75	$-2.78	$1.07	$3.81	$7.66	$10.03	$11.79	$14.92	$5.97	$5.44	$-1.02	$-4.24	$-8.07	$-0.88	$-0.54	$-0.32	$-0.36	$1.23	$1.66
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-0.68%	1.90%	-3.34%	-0.96%	1.27%	0.12%	0.75%	1.25%	1.05%	0.39%	3.29%	1.48%	1.26%	7.52%	4.62%	-0.82%	-7.15%	1.74%	2.16%

According to 1 Wall Street analysts, Braskem's projected average Quarter EPS for Jun 23 is $-1.48, with a low estimate of $-1.65 and a high estimate of $-1.35. This represents a -420.94% decrease compared to BAK previous annual EPS of $0.46 (Mar 23).

Braskem Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
BAK	Braskem	$4.27	$9.25	116.63%	Buy
TROX	Tronox	$10.14	$20.00	97.24%	Buy
GPRE	Green Plains	$10.88	$21.00	93.01%	Buy
CE	Celanese	$68.41	$128.08	87.22%	Buy
DOW	Dow	$40.57	$55.38	36.50%	Hold
ASIX	AdvanSix	$30.10	$39.00	29.57%	Buy
HUN	Huntsman	$18.56	$23.00	23.92%	Buy
WLKP	Westlake Chemical Partners LP	$23.56	$29.00	23.09%	Buy
MEOH	Methanex	$47.12	$57.20	21.39%	Buy
LXU	LSB Industries	$8.25	$10.00	21.21%	Buy

BAK Forecast FAQ

Is Braskem a good buy?

Yes, according to 4 Wall Street analysts, Braskem (BAK) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 75.00% of BAK's total ratings.

What is BAK's price target?

Braskem (BAK) average price target is $9.25 with a range of $8.5 to $10, implying a 130.67% from its last price of $4.01. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Braskem stock go up soon?

According to Wall Street analysts' prediction for BAK stock, the company can go up by 130.67% (from the last price of $4.01 to the average price target of $9.25), up by 149.38% based on the highest stock price target, and up by 111.97% based on the lowest stock price target.

Can Braskem stock reach $6?

BAK's average twelve months analyst stock price target of $9.25 supports the claim that Braskem can reach $6 in the near future.

What are Braskem's analysts' financial forecasts?

Braskem's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $74.26B (high $77.08B, low $71.86B), average EBITDA is $6.19B (high $6.43B, low $5.99B), average net income is $5.99B (high $9.19B, low $2.58B), average SG&A $7.24B (high $8.18B, low $6.32B), and average EPS is $-11.202 (high $-10.238, low $-12.499). BAK's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $95.61B (high $104.12B, low $89.28B), average EBITDA is $7.98B (high $8.69B, low $7.45B), average net income is $-2.389B (high $-2.183B, low $-2.665B), average SG&A $5.68B (high $6.19B, low $5.3B), and average EPS is $-2.997 (high $-2.739, low $-3.344).

Did the BAK's actual financial results beat the analysts' financial forecasts?

Based on Braskem's last annual report (Dec 2022), the company's revenue was $96.52B, beating the average analysts forecast of $95.77B by 0.78%. Apple's EBITDA was $10.16B, missing the average prediction of $-5.128B by -298.12%. The company's net income was $-820M, missing the average estimation of $-62.698B by -98.69%. Apple's SG&A was $4.87B, missing the average forecast of $8.39B by -41.94%. Lastly, the company's EPS was $-2.06, missing the average prediction of $10.05 by -120.50%. In terms of the last quarterly report (Mar 2023), Braskem's revenue was $19.45B, missing the average analysts' forecast of $19.5B by -0.26%. The company's EBITDA was $1.68B, beating the average prediction of $1.63B by 3.55%. Braskem's net income was $184M, missing the average estimation of $14.01B by -98.69%. The company's SG&A was $1.09B, missing the average forecast of $4.19B by -73.92%. Lastly, the company's EPS was $0.46, missing the average prediction of $-0.673 by -168.36%